Delivery Order SPE2DB22D2006-SPE2DB24FW2FX

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Wellbutrin XL 150 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $25,610.70, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and a completion date of January 16, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB24FF3BN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of WELLBUTRIN XL 300 MG TABLET 30S, with a ceiling value of $11,067.76 and a completion date of February 21, 2024. The contract is not designated as a set-aside and appears to be part...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,319.78, is a delivery order for Wellbutrin XL 150 mg tablets. It is a firm fixed price contract with an ultimate completion date of April 2, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, SPE2DB22D2006|SPE2DB25FV9EG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,481.96 firm fixed-price delivery order is for the supply of WELLBUTRIN XL 150 MG TABLET 30S, a mental health treatment medication. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,611,274 units of Wellbutrin XL 150 mg tablets in 30-count packages. The contract has a firm fixed price of $2,754.50 and an ultimate completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,934,873 units of Wellbutrin XL 150 mg tablets with a ceiling value of $2,340.18. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award has an ultimate completion date of March 13, 2024. This appears to be a delivery order placed against a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Wellbutrin XL 150 mg tablets. The potential value of the contract is $1,943.29, and the period of performance is through January 4, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contracts with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the Corporate Office division of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $3,549.62 order is for the supply of 4,564,109,722 tablets of Wellbutrin XL 300 mg to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of WELLBUTRIN XL 300 MG TABLET 30S, a prescription medication, at a ceiling value of $5,997.36. The contract has an ultimate completion date of August 2, 2024. This award is not associated with any set-aside program. Amerisourcebergen has been awarded numerous federal contracts and...
This federal contract award is for the delivery of Wellbutrin XL 300 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,231.40 and an ultimate completion date of November 27, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW2FX
    Delivery Order

This federal contract award, with the ID SPE2DB22D2006|SPE2DB24FW2FX, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of 4,565,264,370 units of the pharmaceutical product Wellbutrin XL 150 mg tablets, with a total ceiling value of $44,329.72. The contract has a firm fixed-price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:50 AM